These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 37597

  • 1. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV, Wyatt RJ.
    Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV, Wyatt RJ.
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL, Piccirilli M, Rizzo PA.
    Riv Neurol; 1984 Jul; 54(3):199-215. PubMed ID: 6147888
    [Abstract] [Full Text] [Related]

  • 6. Management of tardive dyskinesia: current update.
    Simpson GM, Pi EH, Sramek JJ.
    Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noncatecholaminergic treatments of tardive dyskinesia.
    Alphs L, Davis JM.
    J Clin Psychopharmacol; 1982 Dec; 2(6):380-5. PubMed ID: 6129267
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug-induced tardive dyskinesia.
    Itoh H.
    Curr Dev Psychopharmacol; 1981 Dec; 6():93-126. PubMed ID: 6112119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 14. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS, Sauvanaud F, Limosin F.
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [Abstract] [Full Text] [Related]

  • 15. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
    Kulkarni SK, Naidu PS.
    Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107
    [Abstract] [Full Text] [Related]

  • 16. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S.
    Curr Drug Saf; 2016 Jan; 11(1):102-3. PubMed ID: 26391425
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tardive dyskinesia: nondopaminergic treatment approaches.
    Casey DE.
    Psychopharmacology Suppl; 1985 Jan; 2():137-44. PubMed ID: 2860657
    [Abstract] [Full Text] [Related]

  • 20. Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics.
    Chouinard G, Steinberg S.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Jan; 6(4-6):571-8. PubMed ID: 6131490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.